UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old

Journal of acquired immune deficiency syndromes (1999), 2010-10, Vol.55 (2), p.197-204

2010

Volltextzugriff (PDF)

Nonrespiratory Stenotrophomonas maltophilia Infection at a Children's Hospital

Clinical infectious diseases, 2000-12, Vol.31 (6), p.1321-1330

2000

Volltextzugriff (PDF)

Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

The Pediatric infectious disease journal, 2002-10, Vol.21 (10), p.910-916

2002

Volltextzugriff (PDF)

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

Vaccine, 2008-01, Vol.26 (5), p.686-696

2008

Volltextzugriff (PDF)

Stenotrophomonas maltophilia infection in children

The Pediatric infectious disease journal, 2000-09, Vol.19 (9), p.877-878

Sattler, C A

2000

Volltextzugriff (PDF)

The polyploidy and its key role in plant breeding

Planta, 2016-02, Vol.243 (2), p.281-296

2016

Volltextzugriff (PDF)

Nicotine treatment buffers negative behavioral consequences induced by exposure to physical and emotional stress in adolescent male mice

Psychopharmacology, 2020-10, Vol.237 (10), p.3125-3137

2020

Volltextzugriff (PDF)

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Pediatrics (Evanston), 2006-11, Vol.118 (5), p.2135-2145

2006

Volltextzugriff (PDF)

A Genomic Approach to Unravel Host-Pathogen Interaction in Chelonians: The Example of Testudinid Herpesvirus 3

PloS one, 2015-08, Vol.10 (8), p.e0134897-e0134897

2015

Volltextzugriff (PDF)

Spontaneous activity and functional connectivity in the developing cerebellorubral system

Journal of neurophysiology, 2016-09, Vol.116 (3), p.1316-1327

2016

Volltextzugriff (PDF)

PCSK9 Activity Is Potentiated Through HDL Binding

Circulation research, 2021-11, Vol.129 (11), p.1039-1053

2021

Volltextzugriff (PDF)

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

The New England journal of medicine, 2007-05, Vol.356 (19), p.1928-1943

2007

Volltextzugriff (PDF)

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

The New England journal of medicine, 2011-10, Vol.365 (16), p.1482-1491

2011

Volltextzugriff (PDF)

Amplified cold transduction in native nociceptors by M-channel inhibition

The Journal of neuroscience, 2013-10, Vol.33 (42), p.16627-16641

2013

Volltextzugriff (PDF)

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

The Journal of infectious diseases, 2020-07, Vol.222 (Supplement_1), p.S8-S19

2020

Volltextzugriff (PDF)

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus‐like‐particle vaccine in Latin American women

International journal of cancer, 2008-03, Vol.122 (6), p.1311-1318

2008

Volltextzugriff (PDF)

HPV vaccine continues to be safe and effective, and its benefits continue to outweigh its risks

Expert review of vaccines, 2010-07, Vol.9 (7), p.697-701

2010

Volltextzugriff (PDF)

Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines

Clinical and Vaccine Immunology, 2007-06, Vol.14 (6), p.792-795

2007

Volltextzugriff (PDF)

Impact of a Quadrivalent HPV6/11/16/18 Vaccine in Mexican Women: Public Health Implications for the Region

Archives of medical research, 2009-08, Vol.40 (6), p.514-524

2009

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Female
(18)
Humans
(16)
Male
(11)
Adolescent
(10)
Adult
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Immunology
(9)
Infectious Diseases
(9)
Cervical Cancer
(6)
Child
(6)
Human Papillomavirus
(6)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
(6)
Microbiology
(6)
Papillomavirus Infections - Prevention & Control
(6)
Papillomavirus Vaccines - Immunology
(6)
Double-Blind Method
(5)
Papillomaviridae - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old

Nonrespiratory Stenotrophomonas maltophilia Infection at a Children's Hospital

Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

Stenotrophomonas maltophilia infection in children

The polyploidy and its key role in plant breeding

Nicotine treatment buffers negative behavioral consequences induced by exposure to physical and emotional stress in adolescent male mice

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

A Genomic Approach to Unravel Host-Pathogen Interaction in Chelonians: The Example of Testudinid Herpesvirus 3

Spontaneous activity and functional connectivity in the developing cerebellorubral system

PCSK9 Activity Is Potentiated Through HDL Binding

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection

Amplified cold transduction in native nociceptors by M-channel inhibition

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus‐like‐particle vaccine in Latin American women

HPV vaccine continues to be safe and effective, and its benefits continue to outweigh its risks

Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines

Impact of a Quadrivalent HPV6/11/16/18 Vaccine in Mexican Women: Public Health Implications for the Region

Aktive Filter

Suchergebnisse filtern